Approval · Notice of Compliance 9203 · 2007
CAMPTOSAR: Notice of Compliance 9203
Issued November 27, 2007
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 9203
- Date
- November 27, 2007
- Company
- Pfizer Canada UlcKirkland, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Revisions to the indications and clinical use, adverse reactions, dosage and administration, and action and clinical pharmacology sections of the product monograph
- Therapeutic class
- Antineoplastic agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| CAMPTOSAR | Not yet assigned | — |
Medicinal ingredients
- IRINOTECAN HYDROCHLORIDE 20 MG per ML